Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolution of acquired resistance in a ROS1+ KRAS G12C+ NSCLC through the MAPK pathway.
Priest K, Le A, Gebregzabheir A, Nijmeh H, Reis GB, Mandell M, Davies KD, Lawrence C, O'Donnell E, Doebele RC, Bao L, Aisner DL, Schenk EL. Priest K, et al. Among authors: nijmeh h. NPJ Precis Oncol. 2023 Jan 23;7(1):9. doi: 10.1038/s41698-023-00349-0. NPJ Precis Oncol. 2023. PMID: 36690705 Free PMC article.
Tumor Shrinkage With Combination of Alectinib and Trastuzumab in a Patient With ALK-Rearranged Non-small Cell Lung Cancer Harboring HER2-Amplification as an Acquired Resistance Mechanism to ALK Inhibitor Therapy.
Tsui DCC, Aisner D, Nijmeh H, Bao L, Menter A, Camidge DR. Tsui DCC, et al. Among authors: nijmeh h. Clin Lung Cancer. 2022 Mar;23(2):e99-e103. doi: 10.1016/j.cllc.2021.06.012. Epub 2021 Jul 3. Clin Lung Cancer. 2022. PMID: 34330640 No abstract available.
MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC.
Tyler LC, Le AT, Chen N, Nijmeh H, Bao L, Wilson TR, Chen D, Simmons B, Turner KM, Perusse D, Kasibhatla S, Christiansen J, Dudek AZ, Doebele RC. Tyler LC, et al. Among authors: nijmeh h. Thorac Cancer. 2022 Nov;13(21):3032-3041. doi: 10.1111/1759-7714.14656. Epub 2022 Sep 13. Thorac Cancer. 2022. PMID: 36101520 Free PMC article.
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC.
Patil T, Staley A, Nie Y, Sakamoto M, Stalker M, Jurica JM, Koehler K, Cass A, Kuykendall H, Schmitt E, Filar E, Reventaite E, Davies KD, Nijmeh H, Haag M, Yoder BA, Bunn PA, Schenk EL, Aisner DL, Iams WT, Marmarelis ME, Camidge DR. Patil T, et al. Among authors: nijmeh h. JTO Clin Res Rep. 2024 Jan 18;5(2):100637. doi: 10.1016/j.jtocrr.2024.100637. eCollection 2024 Feb. JTO Clin Res Rep. 2024. PMID: 38361741 Free PMC article.
Do More With Less: Tips and Techniques for Maximizing Small Biopsy and Cytology Specimens for Molecular and Ancillary Testing: The University of Colorado Experience.
Aisner DL, Rumery MD, Merrick DT, Kondo KL, Nijmeh H, Linderman DJ, Doebele RC, Thomas N, Chesnut PC, Varella-Garcia M, Franklin WA, Camidge DR. Aisner DL, et al. Among authors: nijmeh h. Arch Pathol Lab Med. 2016 Nov;140(11):1206-1220. doi: 10.5858/arpa.2016-0156-RA. Epub 2016 Sep 9. Arch Pathol Lab Med. 2016. PMID: 27610643 Free PMC article.
20 results